Donepezil study involved 69 people with multiple sclerosis and mild cognitive problems. One – half of the participants took the drug for 24 weeks and the other half took a placebo. The participants were tested for memory and other cognitive functions at the begning and end of the study.
At the study’s conclusion those taking donepezil improved by an average of 14 percent on the memory test, compared to a 3 percent improved for those taking the placebo. 66 percent of those taking the drug felt that their memory had improved, compared to 32 percent of those taking the placebo.
Recent comments
6 hours 23 min ago
6 hours 25 min ago
6 hours 29 min ago
6 hours 37 min ago
1 day 4 hours ago
1 day 7 hours ago
1 day 7 hours ago
1 day 7 hours ago
2 days 14 hours ago
2 days 14 hours ago